Moncef Slaoui Fired by GSK Amid Sexual Harassment Claims
Moncef Slaoui Fired by GSK Amid Sexual Harassment Claims
The former GlaxoSmithKline executive had led the US government’s Operation Warp Speed COVID-19 vaccine program during the Trump administration.
Moncef Slaoui Fired by GSK Amid Sexual Harassment Claims
Moncef Slaoui Fired by GSK Amid Sexual Harassment Claims

The former GlaxoSmithKline executive had led the US government’s Operation Warp Speed COVID-19 vaccine program during the Trump administration.

The former GlaxoSmithKline executive had led the US government’s Operation Warp Speed COVID-19 vaccine program during the Trump administration.

Glaxosmithkline
Pharma’s Ghost Labs Find New Life
Katarina Zimmer | Nov 1, 2019
Finding new tenants for former drug development sites isn’t always easy. But a new, thriving industry has materialized to do just that.
GlaxoSmithKline to Acquire Cancer Biotech TESARO for $5.1 Billion
Carolyn Wilke | Dec 3, 2018
The purchase aims to build GSK’s oncology pipeline.
Novartis and Sanofi Stockpile Meds in Preparation for Brexit
Ashley Yeager | Aug 3, 2018
If the UK leaves the EU in March without a deal, transport of insulin and other essential drugs could be delayed.
Layoffs, Restructuring at GSK
Tracy Vence | Dec 4, 2014
GlaxoSmithKline is eliminating 900 US jobs—most in R&D.
Uncloaking Clinical Trials
Beth Marie Mole | Oct 16, 2012
Glaxo­SmithKline will share long-sought, raw trial data—but access will be tightly controlled.